Thrombopoietic cytokines and platelet count in multiple myeloma.
about
Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment.Dysmegakaryocytopoiesis and maintaining platelet count in patients with plasma cell neoplasm.Bone marrow megakaryocytes, soluble P-selectin and thrombopoietic cytokines in multiple myeloma patients.Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen.Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients.
P2860
Thrombopoietic cytokines and platelet count in multiple myeloma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Thrombopoietic cytokines and platelet count in multiple myeloma.
@en
Thrombopoietic cytokines and platelet count in multiple myeloma.
@nl
type
label
Thrombopoietic cytokines and platelet count in multiple myeloma.
@en
Thrombopoietic cytokines and platelet count in multiple myeloma.
@nl
prefLabel
Thrombopoietic cytokines and platelet count in multiple myeloma.
@en
Thrombopoietic cytokines and platelet count in multiple myeloma.
@nl
P2093
P2860
P1433
P1476
Thrombopoietic cytokines and platelet count in multiple myeloma.
@en
P2093
Gülsan Türköz Sucak
Münci Yağci
Rauf Haznedar
Serafettin Kirazli
Zübeyde Nur Ozkurt
P2860
P356
10.3109/09537100903360007
P577
2010-01-01T00:00:00Z